Flyer: Biologicals drug substance and drug product
Posted: 20 February 2019 | Eurofins CDMO | No comments yet
Eurofins CDMO provides a full suite of drug development services encompassing development of the bioprocesses, formulation screening, analytical development, pre-clinical testing, sterile and non-sterile bio-manufacturing of clinical trial batches and orphan drugs.
We deliver solutions for the development and biomanufacturing of antibodies, proteins, enzymes, vaccines and different types of bacteria.
- Expression optimisation of prokaryotic and eukaryotic organisms including generation of cell banks.
- Development of complete purification process optimised for rapid delivery of high quality material for your preclinical and toxicology studies, and scalable for production of clinical supply for Phase I and beyond.
Related content from this organisation
Related topics
Analytical techniques, Antibodies, Drug Manufacturing, Good Manufacturing Practice (GMP), Manufacturing, Processing, Vaccines